Real-world effectiveness (RWE) and adverse events with sofosbuvir plus ribavirin (SOF+RBV) based therapies in chronic hepatitis C genotype 3 (CHC GT 3) patients in asia-a systematic review of 8 studies and 3510 patient

Authors
Category Systematic review
JournalHepatology
Year 2017
This article has no abstract
Epistemonikos ID: c5c3ee4a25d40e3dae2fbb1a3cd53baf7a527ef6
First added on: Feb 08, 2025